Search Within

Can Gia Pham

Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
  3. Book Section (1)
Groups
  1. Human Oncology and Pathogenesis Program (7)
  2. Department of Medicine (6)
  3. Department of Pathology and Laboratory Medicine (6)
  4. GSK Faculty (6)
  5. Genitourinary Oncology Service (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. James Hsieh (7)
  2. Abraham Hakimi (5)
  3. Emily Cheng (5)
  4. Han Liu (4)
  5. Shugaku Takeda (4)
  6. Angela Brannon (3)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2015 (1)
  4. 2014 (2)
  5. 2013 (3)
Publications
  1. Cancer Cell (1)
  2. Cancer Research (1)
  3. Cell Reports (1)
  4. Clinical Cancer Research (1)
  5. Journal of Clinical Investigation (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Cell Press (2)
  3. American Society for Clinical Investigation (1)
  4. American Society of Clinical Oncology (1)
  5. Nature Publishing Group (1)
  6. Springer New York (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The SWI/SNF protein PBRM1 restrains VHL-loss-driven clear cell renal cell carcinoma
    Journal Article

    Nargund, A. M.; Pham, C. G.; Dong, Y.; Wang, P. I.; Osmangeyoglu, H. U.; Xie, Y.; Aras, O.; Han, S.; Oyama, T.; Takeda, S.; more...
    Cell Reports (2017)

    Fulltext@MSK | Save
  • Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
    Journal Article

    Xu, J.; Pham, C. G.; Albanese, S. K.; Dong, Y.; Oyama, T.; Lee, C. H.; Rodrik-Outmezguine, V.; Yao, Z.; Han, S.; Chen, D.; more...
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save
  • PBRM1: A critical subunit of the SWI/SNF chromatin remodeling complex
    Book Section

    Lee, C. H.; Pham, C. G.; Hsieh, J. J.
    In Bukowski, R. M.; Figlin, R. A.; Motzer, R. J. (Eds.) Renal Cell Carcinoma: Molecular Targets and Clinical Applications. 3rd ed (2015)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Proteasome inhibitors evoke latent tumor suppression programs in Pro-B MLL Leukemias through MLL-AF4
    Journal Article

    Liu, H.; Westergard, T. D.; Cashen, A.; Piwnica-Worms, D. R.; Kunkle, L.; Vij, R.; Pham, C. G.; DiPersio, J.; Cheng, E. H.; Hsieh, J. J.
    Cancer Cell (2014)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A clear picture of renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Pham, C. G.; Hsieh, J. J.
    Nature Genetics (2013)

    Fulltext@MSK | Save